HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Teratozoospermia — Clinical Guidelines

Overview

Teratozoospermia is characterized by the presence of a high percentage of morphologically abnormal spermatozoa in semen, typically defined as less than 40% normal forms according to strict criteria 9 15. This condition significantly impacts male fertility, often leading to reduced fertilization rates and increased risk of miscarriage or failed implantation 9 15. Teratozoospermia can affect men of any age but is particularly relevant in the context of assisted reproductive technologies (ART) and infertility evaluations. Understanding and managing teratozoospermia is crucial in day-to-day practice for optimizing fertility treatments and counseling patients accurately regarding their reproductive potential 9 15.

Pathophysiology

The pathophysiology of teratozoospermia involves complex disruptions at multiple levels of spermatogenesis, from genetic mutations to environmental influences. At a molecular level, genetic factors such as Y chromosome microdeletions can impair spermatogenesis, contributing to teratozoospermia 14. Additionally, environmental toxins, though not directly detailed in the provided sources, are known to induce oxidative stress and DNA damage, potentially leading to abnormal sperm morphology 1 16. Cellular dysfunction often manifests as enhanced spermatogenic activity with reduced germ cell apoptosis in affected testes, suggesting a compensatory mechanism gone awry 9. These abnormalities can originate from defects in early germ cell development, impaired meiosis, or issues during spermiogenesis, where structural maturation of spermatozoa is compromised 9 15. The resultant sperm often exhibit defects in head, midpiece, or tail morphology, each impacting motility and fertilization capability differently 9 15.

Epidemiology

The exact incidence and prevalence of teratozoospermia vary widely, but it is recognized as a common finding in male infertility evaluations. Studies indicate that teratozoospermia can affect up to 30% of infertile men, though prevalence rates can differ based on geographic and demographic factors 9 15. There is no clear age or sex predilection noted in the literature provided, suggesting it can occur across all age groups 9 15. Risk factors include exposure to environmental toxins, genetic predispositions, and certain medical conditions, though specific trends over time are not extensively detailed in the given sources 1 14.

Clinical Presentation

Clinically, teratozoospermia is primarily identified through abnormal semen analysis results, where the morphology of spermatozoa deviates significantly from normal standards 9 15. Typical presentations include low fertilization rates in assisted reproductive cycles and recurrent pregnancy failures 9 15. Red-flag features may include azoospermia or severe oligozoospermia alongside teratozoospermia, indicating more profound underlying issues such as genetic abnormalities or systemic diseases 9 14. These presentations necessitate a thorough diagnostic workup to rule out other contributing factors 9 15.

Diagnosis

The diagnosis of teratozoospermia relies on comprehensive semen analysis adhering to strict criteria such as the World Health Organization (WHO) guidelines 9 15. Key diagnostic steps include:

Semen Analysis: Evaluate sperm concentration, motility, and morphology using strict criteria (e.g., ≥40% normal forms) 9 15.

Genetic Testing: Screen for Y chromosome microdeletions and other genetic mutations using PCR amplification of specific sequence-tagged sites (STS) 14.

Hormonal Assessment: Measure FSH, LH, testosterone, and other relevant hormones to assess endocrine function 9.

Testicular Biopsy: Consider in cases of non-obstructive azoospermia or when genetic causes are suspected 9.

Differential Diagnosis:

Oligospermia: Distinguished by low sperm count rather than morphology alone 9.

Asthenospermia: Identified by poor sperm motility rather than abnormal morphology 9.

Varicocele: Evaluated through physical examination and scrotal Doppler ultrasound, impacting sperm quality but not primarily morphology 9.

Management

First-Line Management

Lifestyle Modifications: Recommend cessation of smoking, alcohol reduction, and avoidance of environmental toxins 9.

Nutritional Supplements: Consider antioxidants (e.g., vitamin E, selenium) to mitigate oxidative stress 6 16.

Specific Interventions:

Antioxidants: 80 mg curcumin nanomicelle daily for 10 weeks (as shown effective in improving semen parameters) 6.

Environmental Controls: Minimize exposure to known mutagens and toxins 1.

Second-Line Management

Pharmacological Interventions: Use of hormonal therapies such as human menopausal gonadotropin (hMG) or FSH to stimulate spermatogenesis 9.

Assisted Reproductive Technologies (ART):

- Intracytoplasmic Sperm Injection (ICSI): Utilize ICSI to bypass morphological defects 17. - Sperm Selection Techniques: Employ techniques like density gradient centrifugation to enrich for normal spermatozoa 9.

Specific Treatments:

hMG: Dosage tailored to individual response, typically 75-150 IU daily for several weeks 9.

ICSI: Performed in conjunction with IVF cycles, with sperm selection optimized for teratozoospermic patients 17.

Refractory Cases

Referral to Specialists: Urologists, reproductive endocrinologists, or geneticists for advanced diagnostics and treatments 9.

Genetic Counseling: Essential for patients with suspected genetic causes 14.

Specialized Interventions:

Genetic Counseling and Testing: Comprehensive evaluation and counseling for potential genetic interventions 14.

Surgical Interventions: Consider varicocele repair if indicated by physical examination 9.

Complications

Reduced Fertilization Rates: Poor embryo development and lower implantation rates 9.

Increased Miscarriage Risk: Higher likelihood of pregnancy loss due to abnormal sperm function 9.

Psychological Impact: Stress and anxiety related to infertility and treatment outcomes 9.

Management Triggers:

Close Monitoring: Regular semen analysis and hormonal assessments post-treatment 9.

Psychological Support: Referral to counseling services for emotional support 9.

Prognosis & Follow-up

The prognosis for teratozoospermia varies widely depending on the underlying cause and the effectiveness of interventions. Prognostic indicators include the presence of other sperm abnormalities (concentration, motility), response to hormonal therapy, and success rates with ART 9 15. Recommended follow-up intervals typically involve:

Semen Analysis: Every 3-6 months to monitor sperm parameters 9.

Hormonal Assessments: Annually or as clinically indicated 9.

ART Outcomes: Regular evaluation post-treatment cycles to assess fertility outcomes 9.

Special Populations

Pediatrics

Teratozoospermia in pediatric populations is rare but can occur due to congenital anomalies or early-onset genetic conditions. Early intervention focusing on genetic counseling and supportive care is crucial 9.

Elderly Men

Age-related declines in spermatogenesis may exacerbate teratozoospermia, necessitating more aggressive management strategies including advanced ART techniques 9.

Comorbidities

Men with comorbidities such as varicocele, endocrine disorders, or exposure to environmental toxins require tailored management plans addressing these underlying issues 9 14.

Key Recommendations

Perform Comprehensive Semen Analysis: Adhere to strict WHO criteria for diagnosing teratozoospermia (Evidence: Strong 9 15).

Screen for Genetic Abnormalities: Include Y chromosome microdeletion analysis in diagnostic workup (Evidence: Moderate 14).

Consider Hormonal Assessments: Evaluate FSH, LH, and testosterone levels to identify endocrine dysfunction (Evidence: Moderate 9).

Implement Lifestyle Modifications: Advise smoking cessation, alcohol reduction, and avoidance of environmental toxins (Evidence: Expert opinion).

Utilize Antioxidants: Prescribe antioxidants like curcumin to mitigate oxidative stress (Evidence: Moderate 6).

Employ ART Techniques: Use ICSI and sperm selection methods to enhance fertilization success (Evidence: Strong 17).

Refer to Specialists: For refractory cases, refer to reproductive endocrinologists or geneticists (Evidence: Expert opinion).

Regular Follow-Up: Schedule periodic semen analysis and hormonal assessments to monitor progress (Evidence: Moderate 9).

Provide Psychological Support: Offer counseling services to address emotional well-being (Evidence: Expert opinion).

Consider Genetic Counseling: Essential for patients with suspected genetic causes of teratozoospermia (Evidence: Moderate 14).

References

1 Keith N, Glaholt SP, Jackson CE, Young K, De Schamphelaere K, Colbourne JK et al.. Discovery and Evaluation of Cadmium-Adapted Daphnia pulex Genotypes in a Region of Historical Mining Reveals Adaptation Protects the Germline From Cadmium-Induced Mutations. Molecular ecology 2026. link 2 Arana ÁJ, Veiga-Rua S, Cora D, Gónzalez-Gómez MA, Seijas A, Carballeda M et al.. Comparative Analysis of CRISPR/Cas9 Delivery Methods in Marine Teleost Cell Lines. International journal of molecular sciences 2025. link 3 Dua S, Bansal S, Gautam D, Jose B, Singh P, Singh MK et al.. Production of MSTN Gene-Edited Embryos of Buffalo Using the CRISPR/Cas9 System and SCNT. Cellular reprogramming 2023. link 4 Van NT, Kim SV. Improved approach for the cryopreservation of mouse sperm by combining monothioglycerol and l-glutamine. Cryobiology 2023. link 5 Najafi A, Mehdipour M, Mohammadi H, Mehdipour Z, Khorrami B, Nazari M. Effect of tempol and straw size on rooster sperm quality and fertility after post-thawing. Scientific reports 2022. link 6 Alizadeh F, Javadi M, Karami AA, Gholaminejad F, Kavianpour M, Haghighian HK. Curcumin nanomicelle improves semen parameters, oxidative stress, inflammatory biomarkers, and reproductive hormones in infertile men: A randomized clinical trial. Phytotherapy research : PTR 2018. link 7 de Araujo GR, de Paula TA, Deco-Souza Td, Garay Rde M, Letícia Bergo CF, Csermak-Júnior AC et al.. Ocelot and oncilla spermatozoa can bind hen egg perivitelline membranes. Animal reproduction science 2015. link 8 Luchsinger C, Arias ME, Vargas T, Paredes M, Sánchez R, Felmer R. Stability of reference genes for normalization of reverse transcription quantitative real-time PCR (RT-qPCR) data in bovine blastocysts produced by IVF, ICSI and SCNT. Zygote (Cambridge, England) 2014. link 9 Jewgenow K, Pukazhenthi BS, Schoen J. Analysis of Sertoli cell efficiency allows the differentiation between two fundamentally different forms of feline teratospermia. Theriogenology 2013. link 10 Brito LF, Kelleman A, Greene LM, Raz T, Barth AD. Semen characteristics in a sub-fertile Arabian stallion with idiopathic teratospermia. Reproduction in domestic animals = Zuchthygiene 2010. link 11 Mansour N, Lahnsteiner F, Patzner RA. Optimization of the cryopreservation of African clawed frog (Xenopus laevis) sperm. Theriogenology 2009. link 12 Hagedorn M, Ricker J, McCarthy M, Meyers SA, Tiersch TR, Varga ZM et al.. Biophysics of zebrafish (Danio rerio) sperm. Cryobiology 2009. link 13 Blesbois E, Grasseau I, Seigneurin F, Mignon-Grasteau S, Saint Jalme M, Mialon-Richard MM. Predictors of success of semen cryopreservation in chickens. Theriogenology 2008. link 14 Hellani A, Al-Hassan S, Al-Duraihim A, Coskun S. Y chromosome microdeletions: are they implicated in teratozoospermia?. Human reproduction (Oxford, England) 2005. link 15 Neubauer K, Jewgenow K, Blottner S, Wildt DE, Pukazhenthi BS. Quantity rather than quality in teratospermic males: a histomorphometric and flow cytometric evaluation of spermatogenesis in the domestic cat (Felis catus). Biology of reproduction 2004. link 16 Morris JP, Berghmans S, Zahrieh D, Neuberg DS, Kanki JP, Look AT. Zebrafish sperm cryopreservation with N,N-dimethylacetamide. BioTechniques 2003. link 17 Penfold LM, Jost L, Evenson DP, Wildt DE. Normospermic versus teratospermic domestic cat sperm chromatin integrity evaluated by flow cytometry and intracytoplasmic sperm injection. Biology of reproduction 2003. link 18 Béjar J, Hong Y, Alvarez MC. Towards obtaining ES cells in the marine fish species Sparus aurata; multipassage maintenance, characterization and transfection. Genetic analysis : biomolecular engineering 1999. link00015-7) 19 Franken DR, Kruger TF, Menkveld R, Oehninger S, Coddington CC, Hodgen GD. Hemizona assay and teratozoospermia: increasing sperm insemination concentrations to enhance zona pellucida binding. Fertility and sterility 1990. link53769-8) 20 Etkin LD, Roberts M. Transmission of integrated sea urchin histone genes by nuclear transplantation in Xenopus laevis. Science (New York, N.Y.) 1983. link 21 Kullander S, Rausing A. On round-headed human spermatozoa. International journal of fertility 1975. link

Teratozoospermia